Cyabra, Inc. (CYAB) is a Nasdaq-listed, Tel Aviv-based software company that sells AI-powered "narrative intelligence" and information-warfare technology — tools that governments, intelligence agencies, and enterprises use to detect coordinated inauthentic activity, bot networks, deepfakes, and impersonation campaigns online. The company began trading publicly in March 2026 after completing a business combination with a special purpose acquisition company.
Shares were down 13.13% at $0.0867 in late-morning trade on Wednesday, against a prior close of $0.0998. The direction is unambiguously negative, and the session extends a sharp reversal that began after Monday's surge. No verified news catalyst was identified for Wednesday's leg lower; the pressure traces to the mechanics of the financing agreement announced earlier in the week.
No verified news or fundamental catalyst found in the current session explains the decline. There was no new press release, SEC filing, analyst rating change, or contract announcement in Wednesday's trade. The most plausible reading is technical and mechanical: the stock is digesting an unusually violent two-session sequence — up 53.71% on Monday on record volume of more than 430 million shares, then down 27.05% on Tuesday — in a name with a very small float and thin resting liquidity. When a micro-cap trades a fraction of its normal volume, a modest imbalance of sell orders can move the price by double digits, which is consistent with the shallow order book reflected in the wide bid-ask spread quoted during the session.
On November 16, Cyabra announced a securities purchase agreement with institutional investors for up to $40 million of new investment over three years, together with the cancellation of roughly $2.8 million of debt. The initial closing covers about $15.6 million — $10 million in cash and $5.6 million in subscription consideration satisfied by debt cancellation — with up to $30 million more available in $500,000 tranches. A separate $50 million equity line of credit is still under negotiation.
The structure is what matters for the share price. The Series D preferred stock converts at an initial price of $0.15 per share, and the accompanying five-year warrants carry the same $0.15 exercise price. Cyabra also agreed to cut the exercise price on existing Series A and Series B warrants covering roughly 16.1 million shares to $0.15 from $0.50 and $0.45. That cluster of supply near $0.15 has acted as a ceiling rather than a floor, and the market has been repricing the equity against a materially larger share count. The initial closing has not occurred and no proceeds have been received; it remains conditional on stockholder approval and on the company resolving its Nasdaq listing deficiencies.
Corporate governance adds to the overhang. At the October annual meeting, holders approved a discretionary reverse split in a range of 1-for-2 to 1-for-30, intended to restore compliance with Nasdaq's minimum bid price requirement. Until that is executed and the financing closes, uncertainty about the capital structure is likely to keep weighing on sentiment.
Volume was light relative to history: roughly 1.3 million shares had changed hands by late morning against a three-month average near 21 million. The move was not part of a broader software or small-cap selloff — the decline is idiosyncratic, driven by company-specific capital-structure news rather than sector rotation. The shares are trading well below both their 50-day and 200-day moving averages and sit only about 15% above the 52-week low of $0.0752, while remaining more than 98% below the 52-week high. Monday's intraday spike to roughly $0.266 failed to hold, and the subsequent failure of the $0.10 area has left that level as nearby resistance.
The score runs from 0 to 100, where 0 represents no meaningful news and a price move entirely normal for the stock, and 100 represents transformative news paired with an extreme, rare move. This event scores 18 out of 100.
Verified news strength was weak for the session itself: the material financing was disclosed two days earlier and has already been digested, leaving no fresh fundamental development to justify Wednesday's selling. The price move, at 13.13%, was about 1.9 times the stock's typical absolute daily change of roughly 7.1% over the last 60 sessions, and moves of that size or larger occurred six times in that window. Two modest components combine into a low overall score.
The near-term agenda is dominated by execution on the financing. Cyabra must convene a shareholder meeting to approve issuance of the shares underlying the Series D preferred and the warrants, satisfy Nasdaq's continued-listing conditions, and complete the initial closing, which is targeted for December 2026. The reverse split range approved by holders gives management flexibility on timing. Third-quarter results were published on November 16, so the next scheduled financial update is the full-year 2026 report; coverage remains thin, with two analysts carrying a Buy consensus on the name. Investors will also watch whether the newly contracted government and media agreements convert into recurring revenue against a trailing-twelve-month top line of roughly $6.9 million and a net loss near $22 million. Key risks include further dilution, failure to close the placement, delisting pressure, and continued liquidity gaps that can produce outsized moves in either direction.
Tickeron operates hundreds of AI trading bots that cover thousands of tickers, but the Trending AI Robots page narrows that universe to only the strongest performers under current market conditions. Bots differ widely by strategy, timeframe, performance metrics, and the symbols they trade, so the curated list gives traders a focused starting point rather than an overwhelming catalog. For volatile micro-caps like CYAB, reviewing which strategies are actually working right now can sharpen decision-making. Explore the page to see the bots leading the current tape.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Aroon Indicator for CYAB entered a downward trend on November 13, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 97 similar instances where the Aroon Indicator formed such a pattern. In 68 of the 97 cases the stock moved lower. This puts the odds of a downward move at 70%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CYAB as a result. In 12 of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 17%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CYAB's RSI Oscillator exited the oversold zone, 10 of 13 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for CYAB just turned positive on October 20, 2026. Looking at past instances where CYAB's MACD turned positive, the stock continued to rise in 9 of 42 cases over the following month. The odds of a continued upward trend are 21%.
Following a +3.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYAB advanced for three days, in 32 of 86 cases, the price rose further within the following month. The odds of a continued upward trend are 37%.
CYAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.130) is normal, around the industry mean (16.275). P/E Ratio (-0.061) is within average values for comparable stocks, (45.369). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.696). Dividend Yield (0.000) settles around the average of (0.430) among similar stocks. P/S Ratio (0.671) is also within normal values, averaging (103.897).
The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. CYAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications